company background image
NEIMETH logo

Neimeth International Pharmaceuticals NGSE:NEIMETH Stock Report

Last Price

₦1.82

Market Cap

₦7.8b

7D

0%

1Y

36.8%

Updated

10 Apr, 2024

Data

Company Financials

Neimeth International Pharmaceuticals Plc

NGSE:NEIMETH Stock Report

Market Cap: ₦7.8b

NEIMETH Stock Overview

Neimeth International Pharmaceuticals Plc manufactures and markets pharmaceutical and animal health care products in Nigeria and Ghana.

NEIMETH fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Neimeth International Pharmaceuticals Plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Neimeth International Pharmaceuticals
Historical stock prices
Current Share Price₦1.82
52 Week High₦2.45
52 Week Low₦1.26
Beta0.33
1 Month Change7.06%
3 Month Change-8.08%
1 Year Change36.84%
3 Year Change-4.21%
5 Year Change225.00%
Change since IPO-11.09%

Recent News & Updates

Recent updates

Shareholder Returns

NEIMETHNG PharmaceuticalsNG Market
7D0%1.3%-1.1%
1Y36.8%11.1%130.4%

Return vs Industry: NEIMETH exceeded the NG Pharmaceuticals industry which returned 10.1% over the past year.

Return vs Market: NEIMETH underperformed the NG Market which returned 131.1% over the past year.

Price Volatility

Is NEIMETH's price volatile compared to industry and market?
NEIMETH volatility
NEIMETH Average Weekly Movement7.6%
Pharmaceuticals Industry Average Movement4.2%
Market Average Movement8.9%
10% most volatile stocks in NG Market12.5%
10% least volatile stocks in NG Market3.3%

Stable Share Price: NEIMETH has not had significant price volatility in the past 3 months.

Volatility Over Time: NEIMETH's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1957202J. Valentine Okeluwww.neimethplc.com.ng

Neimeth International Pharmaceuticals Plc manufactures and markets pharmaceutical and animal health care products in Nigeria and Ghana. The company operates through two segments, Pharmaceuticals and Animal Health. It also provides health care, ethical, and veterinary related products; and poultry and a range of anthelmintic products, as well as enhancing medicaments.

Neimeth International Pharmaceuticals Plc Fundamentals Summary

How do Neimeth International Pharmaceuticals's earnings and revenue compare to its market cap?
NEIMETH fundamental statistics
Market cap₦7.78b
Earnings (TTM)-₦2.58b
Revenue (TTM)₦2.21b

3.5x

P/S Ratio

-3.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NEIMETH income statement (TTM)
Revenue₦2.21b
Cost of Revenue₦1.48b
Gross Profit₦724.67m
Other Expenses₦3.31b
Earnings-₦2.58b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.60
Gross Margin32.80%
Net Profit Margin-116.79%
Debt/Equity Ratio250.5%

How did NEIMETH perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.